×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 1, Part 2: Panel Discussion - Stakeholders Experience Regarding Reliance Procedures
Session Chair(s)
Paul Dearden
Senior Director, Global Regulatory Policy
Biogen, United Kingdom
Panel Discussion: Stakeholders Experience Regarding Reliance Procedures
Speaker(s)
Bandar Al Hammad, MPharm
Saudi Food and Drug Authority (SFDA), Saudi Arabia
Chief Pharmacist, Regulatory Affairs Department
Ghadeer Al-Sheikh Salem
Jordan Food and Drug Administration, Jordan
Head, Originator and Biological Drugs Division, Registration Department
Inas Chehimi
Novartis Pharma Services AG, United Arab Emirates
Executive Director - Regulatory & Policy Head - MEA
Hajed M.H Hashan
Gulf Health Council, Saudi Arabia
Deputy of General Director
Stuart Russel Walker, PhD
Centre for Innovation In Regulatory Science (CIRS), United Kingdom
Professor and Consultant
Rasha Ziada
EDA, Egypt
EDA Chairman Assistant for Technical Development & Capacity Building Affairs
Have an account?